Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. News & events
Filter by
  • Filter by
  • Remove this filter Infectious disease: Vaccine preventable diseases
  • Remove this filter Infectious disease: Influenza
  • Remove this filter Infectious disease: Influenza in humans, seasonal
  • Remove this filter Infectious disease: Influenza A (H1N1)2009
  • Remove this filter Infectious disease: Seasonal influenza
  • Remove this filter Infectious disease: Flu
  • Infectious disease
    • Vaccine preventable diseases (21)
    • Influenza (21)
    • Influenza in humans, seasonal (21)
    • Influenza A (H1N1)2009 (21)
    • Seasonal influenza (21)
    • Flu (21)
    • Respiratory diseases (21)
    • Influenza A (H1N1) (21)
    • Influenza in humans, pandemic (5)
  • Public health area
    • Immunisation (20)
    • Vaccination (20)
    • Active immunisation (20)
    • Vaccine safety (17)
    • Prevention and control (1)
    • Surveillance (1)
    • Antiviral (1)
  • Country
    • Europe (8)
  • Media type
    • News (19)
    • ECDC comment (18)
    • Event (2)
  • All (21)
  • News (19)
  • News (19)
  • Page 1 of 3 // 21 Results found
    • Sort by:

News

WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season

ECDC comment - 3 Oct 2017

The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.

  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Surveillance
Feb 2012

Event

Training workshop on vaccine safety for Member States, building on the experience obtained in the ECDC vaccine safety project VAESCOArchived

Event
23 Feb 2012 - 24 Feb 2012
Stockholm, Sweden
ECDC

ECDC organised a workshop aimed at the Member States not participating in the ECDC Vaccine safety network.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety
Oct 2015

Event

Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines

Event
23 Oct 2015
Geneva, Switzerland
International Alliance for Biological Standardisation and the World Health Organization

​This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.

  • EU/EEA
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Vaccine safety

News

Influenza season 2010/11 – Norway’s risk assessment and revisited vaccine recommendationsArchived

ECDC comment - 19 Jan 2011

​An important conclusion from this process is that the current situation, with B viruses dominating (80%), is likely to continue through the season.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal

News

ECDC – VAESCO investigation into narcolepsyArchived

ECDC comment - 2 Feb 2011

This initiative was taken following the indication of a potential association between the 2009 pandemic influenza A(H1N1) monvalent vaccine and the occurrence of narcolepsy following reports, especially in children from Finland and Sweden.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Influenza vaccine: selection of strains to be included in the seasonal vaccine for the Northern Hemisphere 2011-2012 – Early indications of seasonal vaccine effectiveness in EuropeArchived

ECDC comment - 28 Feb 2011

This recommendation for the Northern Hemisphere is the same as for the season 2010-2011 and for the Southern Hemisphere season.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal

News

Reports of cases of narcolepsy and cataplexy in children and adolescents in Finland, Iceland, and SwedenArchived

ECDC comment - 2 Mar 2011

In February 2011, ECDC published a report concerning a rise in narcolepsy in children and adolescents in some northern countries.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Swedish MPA publishes interim results of a cohort study assessing the risk of narcolepsy after vaccination with Pandemic influenza vaccine Pandemrix®Archived

ECDC comment - 30 Mar 2011

A four-fold increased incidence of narcolepsy in vaccinated children/adolescents compared to unvaccinated children was observed in this register-based cohort study.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Narcolepsy following pandemic influenza A H1N1 2009 vaccination - ECDC update: the European Medicines Agency interim measures for PandemrixArchived

ECDC comment - 27 May 2011

In late March, 2011 ECDC reported that the Swedish Medical Product Agency published preliminary results from an on-going cohort study involving 5.3 million people, where 67% of children and adolescents and 51.0% of adults were vaccinated with Pandemrix.

  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

European Medicines Agency (EMA) 2009 Influenza Pandemic EvaluationArchived

ECDC comment - 30 May 2011

The European Medicines Agency (EMA) was key in the Europe during the 2009 pandemic concerning the authorisation and the benefit – risk assessment of the novel pandemic vaccines.

  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us